Personalis to Participate at Upcoming Investor Conferences
- Participation in investor conferences indicates the company's commitment to engaging with the investment community and showcasing its advancements in precision oncology.
- None.
-
8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
Participating on Monday, August 14, 2023
-
Sidoti Virtual Micro Cap Conference
Presenting on Wednesday, August 16, 2023 at 12:15 p.m. Eastern Time
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in
View source version on businesswire.com: https://www.businesswire.com/news/home/20230801461002/en/
Investors:
Caroline Corner
investors@personalis.com
415-202-5678
Media:
pr@personalis.com
Source: Personalis, Inc.
FAQ
What conferences will Personalis, Inc. participate in?
What is the date of the Sidoti Virtual Micro Cap Conference presentation?
What is Personalis, Inc.'s ticker symbol?